View / Download pdf version of this article

Brand changes for cardiovascular medicines: carvedilol, ezetimibe and ezetimibe with simvastatin

Over the next few months there will be changes in the subsidised brand of three cardiovascular medicines. The first medicine to undergo a brand change was carvedilol on 1 April, 2015, which will be followed by ezetimibe and ezetimibe with simvastatin from 1 June, 2015.

The same Special Authority restrictions for access to ezetimibe and ezetimibe with simvastatin will apply after the brand change.

For further information, see: www.pharmac.health.nz/medicines/my-medicine-has-changed/cardiovascular-medicines/

Patient information can be downloaded and printed from the website or ordered from: www.pharmaconline.co.nz

If you have any enquiries about these changes, please phone 0800 60 00 50 between 9am–5pm, Monday to Friday.

Special Authority forms are available from: www.pharmac.govt.nz/SAForms